Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Els De Droogh"'
Autor:
Els De Droogh, Mick van de Wiel, Sofie Derijcke, Marc Daenen, Elke Vandenbroucke, Erika Saenen, Jan P. van Meerbeeck, Daniella Galdermans, Anna M. Sadowska, Anneke Lefebure, Veerle Surmont, Annelies Janssens, Ann-Marie Morel
Publikováno v:
Clinical lung cancer
Patients with advanced lung cancer and depressive/anxiety symptoms experience worse quality of life (QoL) We examined whether and how coping strategy influenced QoL in these patients. A multicenter cross-sectional study of 125 patients with advanced
Autor:
Erika Saenen, D. Galdermans, Jan P. van Meerbeeck, Anneke Lefebure, Elke Vandenbroucke, Els De Droogh, Annelies Janssens, Sofie Derijcke, Anna M. Sadowska, Ann-Marie Morel, Veerle Surmont
Publikováno v:
Lung cancer.
Introduction: Patients with advanced lung cancer expierence high physical symptom burden with substantial psychological distress. Early palliative care (EPC) addresses the complex suportive care needs improving QOL and mood. The mechanisms are uncert
Autor:
Erika Saenen, Annelies Janssens, Anneke Lefebure, Ann-Marie Morel, Elke Vandenbroucke, Els De Droogh, Marc Daenen, Daniëlle Galdermans, Jan P. van Meerbeeck, Anna M. Sadowska, Veerle Surmont, Sofia Derijcke
Publikováno v:
Clinical lung cancer
Communication about the palliative setting remains difficult for many physicians. This seems a valid concern. Our study has shown that prognostic understanding will be associated with poorer emotional well-being and more pain but not with a worse moo
Autor:
Mark M. Kockx, Els De Droogh, Annelies Janssens, Patrick Pauwels, J. Van Meerbeeck, Paul Germonpré, Anneke Lefebure
Publikováno v:
Acta clinica Belgica
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) is the recommended first-line treatment in metastatic EGFR-mutation-positive non-small cell lung cancer (NSCLC) patients. Such a personalized treatment requires fast EGFR mutatio
Autor:
Els De Droogh, An Vandebroek, Daniella Galdermans, Dirk Schrijvers, Frank Van Fraeyenhove, Abdelbari Baitar, Jeroen Mebis
Publikováno v:
Journal of Geriatric Oncology. 4:32-38
Objective In this study, we evaluated the Groningen Frailty Indicator (GFI) and the G8 questionnaire as screening tools for a Comprehensive Geriatric Assessment (CGA) in older patients with cancer. Patients and Methods Eligible patients with various
Autor:
Jan P. van Meerbeeck, Anneke Lefebure, Julie Jacobs, Koen Deschepper, Thierry Pieters, Erika Saenen, Laure Sorber, Ulrike Himpe, Ingel K. Demedts, Kaat Van Casteren, Frederique Bustin, Karen Zwaenepoel, Christian Rolfo, Xiang Hua Zhang, Els De Droogh, Sofie Derijcke, Patrick Pauwels, Paul Germonpré, Ann-Marie Morel, Koen De Winne, Daniella Galdermans, Elien Augustus
Publikováno v:
Cancers
Cancers, Vol 10, Iss 9, p 290 (2018)
Cancers, Vol. 10, no. 9, p. 290 [1-14] (2018)
Volume 10
Issue 9
Cancers, Vol 10, Iss 9, p 290 (2018)
Cancers, Vol. 10, no. 9, p. 290 [1-14] (2018)
Volume 10
Issue 9
A multicenter study was performed to determine an optimal workflow for liquid biopsy in a clinical setting. In total, 549 plasma samples from 234 non-small cell lung cancer (NSCLC) patients were collected. Epidermal Growth Factor Receptor (EGFR) circ
Autor:
Daniella Galdermans, An Vandebroek, Frank Van Fraeyenhove, Jeroen Mebis, Abdelbari Baitar, Els De Droogh, Dirk Schrijvers
Publikováno v:
Journal of geriatric oncology. 5(2)
Background Screening tools are used in geriatric oncology to determine who should receive a Comprehensive Geriatric Assessment (CGA). However, in this prospective study, we evaluated the association between geriatric screening results, measured with
Autor:
Paul Germonpré, Mark M. Kockx, Patrick Pauwels, Els De Droogh, Anneke Lefebure, Annelies Janssens
Publikováno v:
B22. ADVANCES IN THE TREATMENT OF LUNG CANCER.